| 000 | 01449 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517214311.0 | ||
| 264 | 0 | _c20180806 | |
| 008 | 201808s 0 0 eng d | ||
| 022 | _a1095-6859 | ||
| 024 | 7 |
_a10.1016/j.ygyno.2018.04.572 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKonstantinopoulos, Panagiotis A | |
| 245 | 0 | 0 |
_aPhase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001). _h[electronic resource] |
| 260 |
_bGynecologic oncology _c07 2018 |
||
| 300 |
_a9-13 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAdenocarcinoma, Clear Cell _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnilides _xadministration & dosage |
| 650 | 0 | 4 |
_aFallopian Tube Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPeritoneal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPyridines _xadministration & dosage |
| 700 | 1 | _aBrady, William E | |
| 700 | 1 | _aFarley, John | |
| 700 | 1 | _aArmstrong, Amy | |
| 700 | 1 | _aUyar, Denise S | |
| 700 | 1 | _aGershenson, David M | |
| 773 | 0 |
_tGynecologic oncology _gvol. 150 _gno. 1 _gp. 9-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ygyno.2018.04.572 _zAvailable from publisher's website |
| 999 |
_c28370070 _d28370070 |
||